Pdt Partners, LLC Aquestive Therapeutics, Inc. Transaction History

Pdt Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.64 - $2.57 $64,931 - $260,741	-101,456 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.28 - $4.26 $22,446 - $41,939	9,845 Added 10.75%	101,456 $265,000
Q4 2021 Feb 14, 2022	BUY	$3.69 - $6.37 $57,235 - $98,805	15,511 Added 20.38%	91,611 $356,000
Q3 2021 Nov 15, 2021	SELL	$3.25 - $4.66 $18,411 - $26,398	-5,665 Reduced 6.93%	76,100 $332,000
Q2 2021 Aug 16, 2021	BUY	$3.29 - $5.21 $269,006 - $425,995	81,765 New	81,765 $325,000

Q1 2021 May 17, 2021	SELL	$4.17 - $6.73 $68,746 - $110,950	-16,486 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.65 - $7.79 $404 - $677	87 Added 0.53%	16,486 $88,000
Q3 2020 Nov 16, 2020	BUY	$4.12 - $9.09 $67,563 - $149,066	16,399 New	16,399 $80,000

105

42.1M

463K

431K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $139M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.